Saaim Counsels

February 5, 2026 · Saaim

PLAB vs USMLE for Pakistani Doctors

Pakistani doctors weighing the UK against the USA usually ask which exam is harder. That’s the wrong first question. PLAB and USMLE lead to different systems, different timelines, and different odds — and those differences matter more than difficulty.

PLAB (UK)

PLAB has two parts: PLAB 1 (written, can be sat from Pakistan) and PLAB 2 (practical, must be sat in the UK). Passing both gives you GMC registration, which lets you work as a doctor in the UK. It’s a shorter, more contained process than USMLE, and the route from pass to working is comparatively direct.

USMLE (USA)

USMLE has three steps (Step 1, Step 2 CK, Step 3), and passing them qualifies you to apply for residency — but a residency match isn’t guaranteed. International medical graduates compete for a limited number of residency spots against a large applicant pool, and unmatched years happen. The exam is only half the challenge; matching into a residency program is the other half.

What actually differs

  • Certainty: PLAB’s path to working as a doctor is more predictable. USMLE’s residency match adds real uncertainty even after passing all three steps.
  • Timeline: PLAB can usually be completed faster, since PLAB 2 is the only in-person requirement. USMLE plus the match process typically takes longer.
  • Cost: Both are expensive, but USMLE plus multiple match cycles (if you don’t match on the first attempt) tends to cost more overall.
  • Where it leads: PLAB leads to UK practice. USMLE, if you match, can lead toward US board certification — a longer road with a higher ceiling for some specialties.

Our take

If your priority is a clear, comparatively fast path to practicing medicine abroad, PLAB is usually the more predictable route. If you’re aiming for a specific US specialty and are prepared for a longer timeline with real match risk, USMLE can still make sense — but go in knowing the match is not guaranteed by the exam alone.

Talk to us about which route fits your case.

← Back to all articles